SEC Form 4 · accession 0001144204-16-115762
INTERLEUKIN GENETICS INC · ILIU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen J. DiPalma
Officer — Interim CFO
Period of report
Jul 29, 2016
Accepted (ET)
Aug 1, 2016 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037649
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 29, 2016 | P | 100,603 | $0.0994 | A | 349,855 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) | $0.0994 | Jul 29, 2016 | P | 100,603 | A | Jul 29, 2016 | Jul 29, 2023 | Common Stock | 100,603 | 100,603 | D |